Annual SG&A
N/A
31 December 2023
Summary:
AEON Biopharma annual selling, general & administrative expenses is not available.AEON Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.04 M
-$277.00 K-8.34%
30 September 2024
Summary:
AEON Biopharma quarterly selling, general & administrative expenses is currently $3.04 million, with the most recent change of -$277.00 thousand (-8.34%) on 30 September 2024. AEON quarterly SG&A is now -44.69% below its all-time high of $5.50 million, reached on 31 December 2022.AEON Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.45 B
-$10.53 M-0.73%
30 September 2024
Summary:
AEON Biopharma TTM selling, general & administrative expenses is currently -$1.45 billion, with the most recent change of -$10.53 million (-0.73%) on 30 September 2024. AEON TTM SG&A is now -296.24% below its all-time high of $16.73 million, reached on 30 June 2023.AEON TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AEON Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
AEON Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -44.7% | +25.0% | -206.0% | at low | ||
| 5 y | 5 years | -44.7% | +25.0% | -296.2% | at low | ||
| alltime | all time | -44.7% | +25.0% | -296.2% | at low |
AEON Biopharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.04 M(-8.3%) | $11.01 M(+38.2%) |
| June 2024 | - | $3.32 M(-28.6%) | $7.97 M(-16.9%) |
| Mar 2024 | - | $4.65 M(-6.0%) | $9.60 M(-42.6%) |
| June 2023 | - | $4.95 M(+28.8%) | $16.73 M(+42.0%) |
| Mar 2023 | - | $3.84 M(-30.2%) | $11.78 M(+48.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $13.68 M(+22.6%) | $5.50 M(+125.9%) | $7.94 M(+225.9%) |
| Sept 2022 | - | $2.44 M | $2.44 M |
| Dec 2021 | $11.15 M(-3.7%) | - | - |
| Dec 2020 | $11.59 M(-74.8%) | - | - |
| Dec 2019 | $46.04 M | - | - |
FAQ
- What is the all time high annual SG&A for AEON Biopharma?
- What is AEON Biopharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for AEON Biopharma?
- What is AEON Biopharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for AEON Biopharma?
What is the all time high annual SG&A for AEON Biopharma?
AEON Biopharma all-time high annual selling, general & administrative expenses is $46.04 M
What is AEON Biopharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of AEON is $3.04 M
What is the all time high quarterly SG&A for AEON Biopharma?
AEON Biopharma all-time high quarterly selling, general & administrative expenses is $5.50 M
What is AEON Biopharma TTM selling, general & administrative expenses?
The current TTM SG&A of AEON is -$1.45 B
What is the all time high TTM SG&A for AEON Biopharma?
AEON Biopharma all-time high TTM selling, general & administrative expenses is $16.73 M